This protocol presents a method for generating vascular organoids using human induced pluripotent stem cells.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This protocol presents a method for generating vascular organoids using human induced pluripotent stem cells.
Vascular organoids derived from human pluripotent stem cells (hPSCs) have emerged as powerful three-dimensional models for studying vascular development, disease mechanisms, and drug responses. Current vascular organoid protocols enable the generation of self-organizing endothelial–pericyte networks; however, batch-to-batch variability, inconsistent organoid formation, and inadequate pericyte coverage can compromise reproducibility and scalability. This study presents an optimized protocol for generating vascular organoids from human induced pluripotent stem cells (hiPSCs) with improved reproducibility and structural consistency. Key modifications include refined embryoid body formation conditions, optimized growth factor concentrations and timing during mesoderm induction and vascular specification, and improved three-dimensional culture conditions that promote robust pericyte recruitment and endothelial–pericyte interactions. The optimized organoids exhibit highly branched CD31-positive endothelial networks consistently ensheathed by PDGFR-β-positive pericytes, with significantly reduced batch-to-batch variability compared with the original protocol. Detailed, step-by-step procedures are provided for organoid generation, whole-mount immunofluorescence characterization, and quality control assessment. This optimized method enables the scalable production of high-quality vascular organoids suitable for studying vascular cell interactions, modeling disease, and screening compounds, thereby lowering the technical barrier for laboratories seeking to adopt this model system.
Three-dimensional (3D) organoids have emerged as powerful tools for modeling human organ development and disease in vitro, offering superior structural biomimicry and pathophysiological relevance compared with conventional two-dimensional cell culture models1,2. In recent years, human pluripotent stem cell (hPSC)-derived organoids have been successfully established for multiple tissue types, including the intestine3, brain4,5, kidney6, liver7,8....
Access restricted. Please log in or start a trial to view this content.
The use of hPSCs in this study was approved by the Biomedical Ethics Committee of Anhui University (BECAHU_2026-010).
1. Maintenance of human induced pluripotent stem cells
NOTE: Maintain human induced pluripotent stem cells (hiPSCs) under feeder-free conditions. Perform all procedures in a Class II biological safety cabinet using aseptic technique.
Access restricted. Please log in or start a trial to view this content.
The optimized protocol described here enables the generation of mature vascular organoids from hiPSCs within approximately 15 days using a stepwise differentiation strategy (Figure 1A). Briefly, hiPSC aggregates were generated in low-attachment plates supplemented with 0.25% PVA on an orbital shaker (Day −1). Mesoderm induction was initiated on Day 0 using CHIR99021 (12 µM) and BMP-4 (30 ng/mL) for 3 days, followed by vascular lineage specification with VEGF-A (100 ng/mL) and forskolin (2 µM.......
Access restricted. Please log in or start a trial to view this content.
The optimized protocol described herein introduces several key improvements to the vascular organoid differentiation system originally established by Wimmer et al.18, with the aim of enhancing the homogeneity, reproducibility, and structural integrity of vascular organoid generation. Compared with the original protocol, the optimized method provides significant improvements in the following aspects. First, optimizing aggregate formation conditions substantially improves the homogeneity of embryoid.......
Access restricted. Please log in or start a trial to view this content.
The authors declare no competing financial interests.
This work was supported by the National Natural Science Foundation of China (NSFC) through the Young Scientists Fund (C) (No. 32200655) and the General Program (No. 32270847). The authors also thank the Anhui University Public Service Platform for its support.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 0.22 μm Bottle-Top Filter | Nalgene | FPE204030 | For sterile filtration of media and buffers |
| 15 mL Conical Tube | SparkJade | GD0001 | Sterile |
| 2 mL Microcentrifuge Tube | Eppendorf | 22363204 | Sterile |
| 2-Mercaptoethanol (1000×) | Gibco | 21985023 | Use in fume hood |
| Alexa Fluor 488 AffiniPure F2 Fragment Donkey Anti-Rabbit IgG (H+L) | Lablead | Y1104 | Secondary antibody; dilute 1:300 |
| Alexa Fluor 594 AffiniPure F(ab′)2 Fragment Donkey Anti-Goat IgG (H+L) | Lablead | Y1007 | Secondary antibody; dilute 1:300 |
| Anti-CD31 antibody | Cell Signaling | 3528s | Primary antibody; dilute 1:100 in blocking buffer |
| Anti PDGFR β antibody | Zenbio | 347269 | Primary antibody; dilute 1:100 in blocking buffer |
| Automated Cell Counter | Life Technologies | Countess™ II | Includes counting chamber slides |
| B27 Supplement (50×) | Gibco | 17504044 | For N2B27 medium; thaw at 4ºC, aliquot and store at −20ºC, avoid freeze-thaw |
| Benchtop Centrifuge | Zonkia | SC-3610 | With swinging-bucket rotor |
| Biological Safety Cabinet (Class II) | Thermo Fisher | NA | NA |
| BMP4 | Proteintech | HZ-1045 | Reconstitute in sterile ddH2O to 100 ng/μL, aliquot and store at −20 °C |
| Bovine Serum Albumin (BSA) | Biosharp | 9048-46-8 | For blocking buffer |
| CHIR99021 | MCE | HY-10182 | Prepare 10 mM stock in DMSO, store at −20ºC for up to 1 year |
| CO2 Incubator | Fisher Scientific | LS-CO150 | 37 ºC, 5% CO2, humidified |
| Confocal Imaging Dish | Biosharp | BS-20-GJM | For imaging after staining |
| Confocal Microscope | LEICA | NA | Equipped with 10×, 20×, 63× objectives and ZEN software |
| DMEM | Vivacell | C3113-0500 | For Matrigel dilution and collagen I solution |
| DMEM/F-12, GlutaMAX Supplement | Gibco | 10565018 | For Matrigel dilution and N2B27 medium |
| EDTA (0.5 M, pH 8.0) | Invitrogen | AM9260G | Dilute with PBS to 0.02% for passaging |
| Fetal Bovine Serum (FBS) | Gibco | 10270-106 | For N2B27 complete differentiation medium (15% final) |
| FGF-2 | Novoprotein | C046 | Prepare 1 mg/mL stock in sterile PBS, aliquot and store at −20ºC |
| Forskolin | R&D Systems | 1099 | Prepare 10 mM stock in DMSO, store at −20ºC |
| HEPES (1M) | Gibco | 15630080 | For collagen I solution |
| Hoechst | Beyotime | C1071S-4 | Prepare 1 mg/mL stock in deionized water, aliquot and store at −20ºC |
| Inverted Microscope | LEICA | DMIL LED | Routine cell observation |
| Matrigel (growth factor-reduced) | STEEMA | BM05 | Store at −20ºC after aliquoting, avoid freeze-thaw; handle on ice |
| MEM Non-Essential Amino Acids Solution (NEAA, 100×) | Gibco | 11140035 | For N2B27 medium |
| N2 Supplement (100×) | Gibco | 17502048 | For N2B27 medium; store at −20ºC protected from light |
| Neurobasal Medium | Gibco | 21103049 | For N2B27 medium |
| Nuclease Free Water (DNase/Rnase Free) | Lablead | Doo55WJ | For RNA/cDNA preparation and qPCR |
| Orbital Shaker | Joan Lab | NA | For washing steps |
| Paraformaldehyde (4% solution) | Servicebio | G1101 | Dilute with PBS to 4% for fixation; use in fume hood |
| Penicillin-Streptomycin (100×) | Gibco | 15140122 | For N2B27 medium |
| PGM1 Medium | Cellapy | A1517001 | hiPSC expansion medium; store at 4ºC protected from light, stable for 2 weeks |
| PGM1 Supplement (25×) | Cellapy | A1517101 | For use with PGM1 Basal Medium |
| Polyvinyl Alcohol (PVA) | Sigma-Aldrich | P8136 | Dissolve in PGM1 at 0.25% (w/v) to promote aggregation |
| PureCol (Bovine Type I Collagen, 3 mg/mL) | Advanced BioMatrix | 5005 | For collagen I-Matrigel mixture; test batch for polymerization capacity |
| qPCR Thermal Cycler | Thermo Fisher | StepOnePlus™ | With melt curve capability; for real-time PCR detection |
| Reverse Transcription Kit | Accurate Biology | AG11706 | For cDNA synthesis from total RNA; contains RT master mix with reverse transcriptase, buffer, dNTPs, and random primers |
| RNA Extraction Kit | Yeasen | 19221ES50 | For total RNA isolation from vascular organoids; includes gDNA elimination columns and RNase-free DNase I |
| Sodium Bicarbonate (7.5%) | Gibco | 25080094 | For collagen I solution |
| Sodium Deoxycholate | Sigma-Aldrich | D6750 | Prepare 1% (w/v) solution in deionized water for blocking buffer |
| Sodium Hydroxide (1.0 N) | Sigma-Aldrich | S2770 | For pH adjustment of collagen I solution |
| Sterile Disposable Pipettes (10 mL) | Bkmamlab | 110205007 | Individually wrapped, sterile |
| Sterile Filter Pipette Tips (1000, 200, 20 μL) | Biozym | VT0270/VT0250/VT0220 | Sterile, with filter |
| Sterile Needle (30 G) | NA | NA | For dissecting vascular networks |
| Sterile Spatula (Round End) | Fisher Scientific | 21-401-5 | Stainless steel |
| SYBR Green Master Mix | Accurate Biology | AG11733 | 2× concentration for qPCR; contains hot-start DNA polymerase, buffer, dNTPs, and SYBR Green dye |
| Tissue Culture-Treated 12-Well Plate | BD Falcon | 353043 | For gel embedding and vascular network culture |
| Tissue Culture-Treated 6-Well Plate | Eppendorf | 30720113 | Standard TC-treated |
| Triton X-100 | Sigma-Aldrich | T9084 | For blocking buffer |
| Trypan Blue (0.4%) | Thermo Fisher | 15250061 | For cell counting |
| Tween 20 | Sigma-Aldrich | P7949 | For 0.05% PBS-T wash solution |
| Ultra-Low Attachment 6-Well Plate | Corning | 3471 | For aggregate formation and differentiation |
| Ultra-Low Attachment Round-Bottom 96-Well Plate | Beyotime | FULA962-6pcs | For suspension culture of vascular organoids |
| VEGF-A | Proteintech | HZ-1038 | Prepare 1 mg/mL stock in sterile PBS, aliquot and store at −20ºC |
| Water Bath | Blue pard | HWS-24 | 37ºC |
| Y-27632 | MCE | HY-10071 | Prepare 10 mM stock in sterile PBS or DMSO, store at −20ºC; working concentrations: 5 μM (thawing), 50 μM (aggregate formation) |
Access restricted. Please log in or start a trial to view this content.